{"product_id":"gardasil-9-vials-hpv-vaccine-10-pack","title":"Gardasil 9 Human Papillomavirus Vaccine (HPV vaccine) Recombinant, 20 mcg - 60 mcg (10-Pack) **Requires Refrigeration (RX)","description":"\u003cp\u003eGardasil 9 is a Human Papillomavirus (HPV) vaccine used to protect against cancers caused by HPV, including cervical, anal, and throat cancers, as well as genital warts. It offers protection against nine HPV types, significantly reducing the risk of infection. Administered through a series of injections, this vaccine plays a crucial role in preventive healthcare. It is effective in promoting immune protection and enhancing overall public health by reducing HPV-related disease prevalence.\u003c\/p\u003e\n\u003cp\u003eGardasil 9 is a leading vaccine designed to provide robust protection against certain strains of Human Papillomavirus (HPV). Manufactured by Merck, this recombinant vaccine targets nine HPV types—6, 11, 16, 18, 31, 33, 45, 52, and 58—responsible for the majority of HPV-related cancers and diseases. With its advanced formulation, Gardasil 9 empowers individuals to safeguard their health and reduce the risk of developing HPV-related cervical, vulvar, vaginal, anal, and oropharyngeal cancers, as well as genital warts.\u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eDetails and Features:\u003c\/strong\u003e\u003c\/p\u003e\n\u003cul\u003e\n\u003cli\u003e\n\u003cstrong\u003eDosage Strengths:\u003c\/strong\u003e Offers antigen levels ranging from 20 mcg to 60 mcg, tailored to confer optimal immunity.\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eComprehensive Protection:\u003c\/strong\u003e Covers nine HPV types responsible for approximately 90% of cervical cancer cases.\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eTarget Audience:\u003c\/strong\u003e Approved for use in both males and females, typically starting from ages 9 to 45.\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eFormulation:\u003c\/strong\u003e Recombinant vaccine, meaning it uses a safe, non-infectious virus-like particle (VLP) to elicit an immune response.\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eAdministration:\u003c\/strong\u003e Administered via intramuscular injection, typically in a series of two or three doses depending on the age and health status of the recipient.\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003cp\u003e\u003cstrong\u003eMechanism of Action:\u003c\/strong\u003e\u003c\/p\u003e\n\u003cp\u003eGardasil 9 works by introducing non-infectious VLPs resembling the HPV virus to the body. This prompts the immune system to produce antibodies, equipping the body to recognize and neutralize the actual virus if exposed in the future. The vaccine does not contain live virus, ensuring safety while effectively stimulating a protective immune response.\u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eDirections for Use:\u003c\/strong\u003e\u003c\/p\u003e\n\u003col\u003e\n\u003cli\u003e\n\u003cp\u003e\u003cstrong\u003eVaccination Schedule:\u003c\/strong\u003e\u003c\/p\u003e\n\u003cul\u003e\n\u003cli\u003e\n\u003cstrong\u003eAges 9-14:\u003c\/strong\u003e Two doses, with a second dose given 6-12 months after the first.\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eAges 15-45 and Immunocompromised Individuals:\u003c\/strong\u003e Three doses, with the second and third doses given two and six months after the first, respectively.\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003c\/li\u003e\n\u003cli\u003e\n\u003cp\u003e\u003cstrong\u003eRoute of Administration:\u003c\/strong\u003e Administered intramuscularly, typically in the upper arm or thigh.\u003c\/p\u003e\n\u003c\/li\u003e\n\u003c\/ol\u003e\n\u003cp\u003e\u003cstrong\u003eWarnings:\u003c\/strong\u003e\u003c\/p\u003e\n\u003cul\u003e\n\u003cli\u003e\n\u003cstrong\u003eAllergic Reactions:\u003c\/strong\u003e Immediate medical attention is required for severe allergic reactions, such as difficulty breathing, wheezing, hives, or swelling.\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003ePregnancy and Breastfeeding:\u003c\/strong\u003e Not recommended for pregnant women; if pregnancy is discovered post-vaccination, notify your healthcare provider. Consult a doctor before receiving the vaccine while breastfeeding.\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eSyncope (Fainting):\u003c\/strong\u003e Patients should be observed for at least 15 minutes post-vaccination to manage any immediate adverse reactions, including fainting.\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003cp\u003e\u003cstrong\u003eSide Effects:\u003c\/strong\u003e\u003c\/p\u003e\n\u003cp\u003eCommon side effects may include:\u003c\/p\u003e\n\u003cul\u003e\n\u003cli\u003eInjection-site reactions: Pain, swelling, or redness\u003c\/li\u003e\n\u003cli\u003eHeadache\u003c\/li\u003e\n\u003cli\u003eFever\u003c\/li\u003e\n\u003cli\u003eNausea\u003c\/li\u003e\n\u003cli\u003eDizziness\u003c\/li\u003e\n\u003cli\u003eFatigue\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003cp\u003eMost side effects are mild and resolve on their own. Contact your healthcare provider if you experience persistent or severe symptoms.\u003c\/p\u003e\n\u003cp\u003eGardasil 9 is a pivotal tool in the prevention of HPV-related diseases. Consult your healthcare provider to learn if Gardasil 9 is appropriate for you or your loved ones, and take proactive steps to protect against HPV.\u003c\/p\u003e","brand":"Merck","offers":[{"title":"Default Title","offer_id":53335246668094,"sku":"00006-4121-02","price":390583.99,"currency_code":"INR","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0872\/3408\/5182\/files\/Gardasil-9-Human-Papillomavirus-Vaccine-Syringes.jpg?v=1776754289","url":"https:\/\/himkhand.com\/products\/gardasil-9-vials-hpv-vaccine-10-pack","provider":"Himkhand","version":"1.0","type":"link"}